Latest / The Podcast by KevinMD

Exploring promising breakthroughs in Alzheimer's research
Join Ken Blaker, a health care and technology consultant, and Cuong Do, a health care executive, as they shed light on the latest developments in combating these challenging conditions. From the recent FDA approval of Leqembi to promising anti-neuroinflammation drugs and genetic approaches, we uncover the cutting-edge strategies that could change the future of Alzheimer's care.
Ken Blaker is a Los Angeles-based health care and technology consultant focused on medical devices and FDA compliance. As an author, Ken has written on a variety of topics, including treatments for neurodegenerative…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.